St. Jude Paces Large Caps In Q3; Index Composite Bucks Market Decline
This article was originally published in The Gray Sheet
Executive Summary
Medicare's decision to cover anticoagulation home monitoring for patients with mechanical heart valves, combined with dependable operating results and a promising product portfolio made St. Jude Medical a third-quarter standout among the 27 issues on "The Gray Sheet" Index of NYSE and AMEX device and diagnostics stocks.